Paul Angulo

Paul Angulo

UNVERIFIED PROFILE

Are you Paul Angulo?   Register this Author

Register author
Paul Angulo

Paul Angulo

Publications by authors named "Paul Angulo"

Are you Paul Angulo?   Register this Author

100Publications

1001Reads

47Profile Views

Right upper-quadrant pain in a patient with drug abuse, secondary syphilis and occult hepatitis B virus.

Med Princ Pract 2014 18;23(5):471-4. Epub 2014 Mar 18.

Department of Internal Medicine, University of Kentucky, Lexington, Ky., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586908PMC
June 2015

The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.

Dig Dis Sci 2015 May 25;60(5):1440-7. Epub 2014 Dec 25.

Department of Pediatric Gastroenterology and Hepatology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-014-3494-7DOI Listing
May 2015

Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.

Semin Liver Dis 2015 May 14;35(2):132-45. Epub 2015 May 14.

Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1550065DOI Listing
May 2015

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

Dig Liver Dis 2015 Mar 18;47(3):181-90. Epub 2014 Nov 18.

AUSL Modena and University of Modena and Reggio Emilia, Department of Biomedical, Metabolic and Neural Sciences, Division of Internal Medicine, NOCSAE - Baggiovara, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2014.09.020DOI Listing
March 2015

Noninvasive prediction of hepatic steatosis.

Am J Gastroenterol 2014 Sep;109(9):1415-6

1] Department of Medicine, University of Kentucky Medical Center, Lexington, Kentucky, USA [2] Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington, Kentucky, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ajg2014265
Publisher Site
http://dx.doi.org/10.1038/ajg.2014.265DOI Listing
September 2014

Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.

Clin Gastroenterol Hepatol 2014 Jul 14;12(7):1163-1169.e1. Epub 2013 Dec 14.

Division of Gastroenterology and Hepatology, Department of Medical Sciences, University of Torino, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.11.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057997PMC
July 2014

Hepatic steatosis and steatohepatitis: Are they really two distinct entities?

Curr Hepatol Rep 2014 Jun;13(2):151-158

Division of Digestive Diseases and Nutrition, Department of Internal Medicine, University of Kentucky, Lexington, KY, 800 Rose Street, Room MN649, Lexington, KY 40536-0298, (859) 323-3555 office, (859) 257-8860 fax,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11901-014-0227-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066391PMC
June 2014

Strengthening the bones in primary biliary cirrhosis.

Authors:
Paul Angulo

Hepatology 2013 Dec 17;58(6):1871-3. Epub 2013 Oct 17.

Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington, KY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856251PMC
December 2013

PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation.

J Surg Res 2013 Nov 25;185(1):225-30. Epub 2013 May 25.

Department of Surgery, University of Kentucky, College of Medicine, Lexington, Kentucky. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2013.05.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390173PMC
November 2013

Noninvasive evaluation of NAFLD.

Nat Rev Gastroenterol Hepatol 2013 Nov 24;10(11):666-75. Epub 2013 Sep 24.

Department of Hepatology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Université Paris Sorbonne Cité, and INSERM CRB3, Centre de Recherche Biomédicale Bichat-Beaujon, Unité 773, 100 Boulevard du Général Leclerc, 92110 Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2013.175DOI Listing
November 2013

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

Gastroenterology 2013 Oct 13;145(4):782-9.e4. Epub 2013 Jul 13.

Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington, Kentucky. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.06.057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931256PMC
October 2013

Risk factors for venous thromboembolism in patients with chronic liver disease.

Ann Pharmacother 2013 Mar 12;47(3):333-9. Epub 2013 Mar 12.

University of Kentucky Chandler Medical Center/UKHealthCare, Lexington, KY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1R496DOI Listing
March 2013

Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.

Clin Gastroenterol Hepatol 2012 Sep 18;10(9):1028-33.e2. Epub 2012 May 18.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2012.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424335PMC
September 2012

PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.

J Surg Res 2012 Aug 21;176(2):542-8. Epub 2011 Nov 21.

Department of Surgery, University of Kentucky, College of Medicine, Lexington, Kentucky 40536-0293, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2011.10.045DOI Listing
August 2012

Can NASH be diagnosed, graded, and staged noninvasively?

Clin Liver Dis 2012 Aug 26;16(3):567-85. Epub 2012 Jun 26.

Division of Digestive Diseases & Nutrition, Department of Medicine, University of Kentucky Medical Center, Lexington, 40536-0298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2012.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405360PMC
August 2012

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

Liver Int 2012 Jul 2;32(6):945-50. Epub 2012 Feb 2.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2011.02753.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348257PMC
July 2012

The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease.

Dig Dis Sci 2012 Jul 29;57(7):1925-31. Epub 2012 Feb 29.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-012-2098-3DOI Listing
July 2012

The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.

Anticancer Res 2012 Jul;32(7):2531-6

Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY, USA.

View Article

Download full-text PDF

Source
July 2012

Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association?

Gastroenterol Hepatol (N Y) 2012 Apr;8(4):281-3

Division of Digestive Diseases & Nutrition University of Kentucky Medical Center Lexington, Kentucky.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380268PMC
April 2012

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

Hepatology 2011 Oct 9;54(4):1208-16. Epub 2011 Aug 9.

Clinical Trial Service Unit & Epidemiological Studies Unit, Richard Doll Building, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238674PMC
October 2011

Varices in early histological stage primary biliary cirrhosis.

J Clin Gastroenterol 2011 Aug;45(7):e66-71

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e3181f18c4eDOI Listing
August 2011

Nonalcoholic fatty liver disease: what are the odds your patient will get a transplant?

Clin Gastroenterol Hepatol 2011 Aug 30;9(8):631-2. Epub 2011 May 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2011.05.018DOI Listing
August 2011

Clinical trials: Trial design in NASH--realities and challenges.

Authors:
Paul Angulo

Nat Rev Gastroenterol Hepatol 2011 Aug 5;8(8):424-5. Epub 2011 Aug 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2011.125DOI Listing
August 2011

Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.

Arch Surg 2011 Aug;146(8):953-8

Transplant Center, University of Kentucky College of Medicine, Lexington, KY 40536-0293, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.2011.186DOI Listing
August 2011

Bone disease in patients with primary sclerosing cholangitis.

Gastroenterology 2011 Jan 16;140(1):180-8. Epub 2010 Oct 16.

Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2010.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043598PMC
January 2011

PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

Anticancer Res 2010 Dec;30(12):4951-8

Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY 40536, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141822PMC
December 2010

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

Am J Gastroenterol 2010 Jul 9;105(7):1567-73. Epub 2010 Feb 9.

School of Medicine and Pharmacology, The University of Western Australia, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ajg201018
Publisher Site
http://dx.doi.org/10.1038/ajg.2010.18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898908PMC
July 2010

Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

Dig Dis Sci 2010 Feb 3;55(2):476-83. Epub 2009 Mar 3.

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-009-0744-1
Publisher Site
http://dx.doi.org/10.1007/s10620-009-0744-1DOI Listing
February 2010

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

Am J Gastroenterol 2008 Sep 5;103(9):2263-71. Epub 2008 Aug 5.

Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2008.02034.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574666PMC
September 2008

Cholangiocarcinoma in pregnancy: a case report.

J Obstet Gynaecol Res 2008 Aug;34(4 Pt 2):635-7

Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1447-0756.2008.00810.xDOI Listing
August 2008

Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.

Dig Dis Sci 2008 Jun;53(6):1716-20

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-007-0052-6DOI Listing
June 2008

The natural history of small-duct primary sclerosing cholangitis.

Gastroenterology 2008 Apr 17;134(4):975-80. Epub 2008 Jan 17.

Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.01.042DOI Listing
April 2008

Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.

Hepatology 2008 Jan;47(1):133-42

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.21960DOI Listing
January 2008

Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia.

Am J Gastroenterol 2007 Sep 17;102(9):1912-9. Epub 2007 May 17.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2007.012
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2007.01274.xDOI Listing
September 2007

[Auto-antibodies in liver disease].

Rev Gastroenterol Mex 2007 Jan-Mar;72(1):62-8

Division of Gastroenterology and Hepatology, Mayo Clinic, College of Medicine, 200 First Street S.W., Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
September 2007

Non-alcoholic fatty liver disease.

Scand J Gastroenterol 2007 Sep;42(9):1023-30

Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520701514529DOI Listing
September 2007

Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.

Am J Gastroenterol 2007 Aug 13;102(8):1677-82. Epub 2007 Apr 13.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2007.012
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2007.01220.xDOI Listing
August 2007

Hepatitis C and steatosis.

Arch Med Res 2007 Aug;38(6):621-7

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2006.09.001DOI Listing
August 2007

Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.

Am J Gastroenterol 2007 Jun 23;102(6):1244-50. Epub 2007 Feb 23.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2007.011
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2007.01136.xDOI Listing
June 2007

Obesity and nonalcoholic fatty liver disease.

Authors:
Paul Angulo

Nutr Rev 2007 Jun;65(6 Pt 2):S57-63

Miles and Shirley Fiterman Center for Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1753-4887.2007.tb00329.xDOI Listing
June 2007

Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.

Liver Int 2007 Mar;27(2):220-6

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2006.01404.xDOI Listing
March 2007

Abnormal hepatic biochemistries in patients with inflammatory bowel disease.

Am J Gastroenterol 2007 Feb 13;102(2):344-50. Epub 2006 Nov 13.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2006.00947.xDOI Listing
February 2007

Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.

Clin Gastroenterol Hepatol 2007 Feb 15;5(2):259-64. Epub 2006 Dec 15.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2006.09.031DOI Listing
February 2007

Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.

Clin Liver Dis 2007 Feb;11(1):25-35, viii

School of Medicine and Pharmacology, The University of Western Australia, Liver Transplant Unit, Sir Charles Gairdner Hospital, Nedlands, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108932610700005
Publisher Site
http://dx.doi.org/10.1016/j.cld.2007.02.004DOI Listing
February 2007

Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis.

Liver Int 2006 Dec;26(10):1209-16

Gastroenterology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2006.01362.xDOI Listing
December 2006

Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Gastroenterology 2006 Oct 10;131(4):1057-63. Epub 2006 Aug 10.

Advanced Liver Disease Study Group and Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2006.08.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483536PMC
October 2006

NAFLD, obesity, and bariatric surgery.

Authors:
Paul Angulo

Gastroenterology 2006 May;130(6):1848-52

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001650850600707
Publisher Site
http://dx.doi.org/10.1053/j.gastro.2006.03.041DOI Listing
May 2006

Nonalcoholic fatty liver disease and liver transplantation.

Authors:
Paul Angulo

Liver Transpl 2006 Apr;12(4):523-34

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lt.20738DOI Listing
April 2006

The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.

Liver Int 2006 Apr;26(3):298-304

Department of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2005.01238.xDOI Listing
April 2006

Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

J Hepatol 2005 Dec 11;43(6):1060-6. Epub 2005 Jul 11.

Gastroenterology and Hepat ology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016882780500435
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2005.06.008DOI Listing
December 2005

The bulge, booze, and the liver.

Clin Gastroenterol Hepatol 2005 Dec;3(12):1195-7

View Article

Download full-text PDF

Source
December 2005

[Cholestatic syndromes].

Authors:
Paul Angulo

Rev Gastroenterol Mex 2005 Nov;70 Suppl 3:45-51

Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine.

View Article

Download full-text PDF

Source
November 2005

Nonalcoholic fatty liver disease.

Authors:
Paul Angulo

Rev Gastroenterol Mex 2005 Nov;70 Suppl 3:52-6

Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
November 2005

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.

Hepatology 2005 Oct;42(4):762-71

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20866DOI Listing
October 2005

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.

Dig Dis Sci 2005 Sep;50(9):1734-40

Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-005-2927-8DOI Listing
September 2005

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Liver Int 2005 Aug;25(4):779-86

Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2005.01064.xDOI Listing
August 2005

The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Gastroenterology 2005 Jul;129(1):113-21

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2005.04.014DOI Listing
July 2005

Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.

Am J Gastroenterol 2005 Jun;100(6):1330-3

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.415
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2005.41526.xDOI Listing
June 2005

Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease.

Clin Gastroenterol Hepatol 2005 Apr;3(4):384-9

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
April 2005

Nonalcoholic fatty liver disease.

CMAJ 2005 Mar;172(7):899-905

Division of Gastroenterology and Hepatology, Mayo Clinic and College of Medicine, Rochester, Minn 55905, USA.

View Article

Download full-text PDF

Source
http://www.cmaj.ca/cgi/doi/10.1503/cmaj.045232
Publisher Site
http://dx.doi.org/10.1503/cmaj.045232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC554876PMC
March 2005

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.

Am J Gastroenterol 2005 Feb;100(2):308-12

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 SW First Street, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.404
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2005.40484.xDOI Listing
February 2005

Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

J Clin Gastroenterol 2005 Feb;39(2):168-71

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
February 2005

Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.

Liver Int 2005 Feb;25(1):117-21

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2005.01026.xDOI Listing
February 2005

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

J Hepatol 2005 Jan;42(1):132-8

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016882780400435
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2004.09.012DOI Listing
January 2005

Chronological development of elevated aminotransferases in a nonalcoholic population.

Hepatology 2005 Jan;41(1):64-71

Department of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.20543
Publisher Site
http://dx.doi.org/10.1002/hep.20543DOI Listing
January 2005

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

Am J Gastroenterol 2004 Dec;99(12):2365-8

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2004.40064.xDOI Listing
December 2004

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.

J Hepatol 2004 Dec;41(6):943-9

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2004.08.020DOI Listing
December 2004

Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?

Clin Gastroenterol Hepatol 2004 Dec;2(12):1059-60

View Article

Download full-text PDF

Source
December 2004

[Fatty liver and steatotic non-alcoholic hepatitis].

Authors:
Paul Angulo

Rev Gastroenterol Mex 2004 Nov;69 Suppl 3:140-8

Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic and Foundation, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
November 2004

The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.

Am J Gastroenterol 2004 Jul;99(7):1316-20

Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic and Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2004.30444.xDOI Listing
July 2004

Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.

Hepatology 2004 Jul;40(1):39-45

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20287DOI Listing
July 2004

Treatment of nonalcoholic fatty liver disease.

Authors:
Paul Angulo

Ann Hepatol 2002 Jan-Mar;1(1):12-9

Division of Gastroenterology & Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
May 2004

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.

Hepatology 2004 Apr;39(4):909-14

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20140DOI Listing
April 2004

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

Am J Gastroenterol 2004 Mar;99(3):523-6

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2004.04067.xDOI Listing
March 2004

Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?

J Hepatol 2004 Mar;40(3):380-4

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2003.11.033DOI Listing
March 2004

Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.

Am J Gastroenterol 2004 Feb;99(2):269-70

View Article

Download full-text PDF

Source
February 2004

Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis.

Hepatology 2004 Jan;39(1):204-10

Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic and Foundation, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.20029DOI Listing
January 2004

Association of primary biliary cirrhosis and rheumatoid arthritis.

J Clin Rheumatol 2003 Dec;9(6):340-3

Divisions of Gastroenterology and Hepatology, and Rheumatology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.rhu.0000099623.30805.2fDOI Listing
December 2003

Recurrent idiopathic hepatitis: a new entity?

J Clin Gastroenterol 2003 Sep;37(3):267-9

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004836-200309000-00014DOI Listing
September 2003

Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis.

J Clin Gastroenterol 2003 Aug;37(2):183-5

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004836-200308000-00018DOI Listing
August 2003

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Gastroenterology 2003 Aug;125(2):437-43

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55905 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0016-5085(03)00907-7DOI Listing
August 2003

When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

Clin Gastroenterol Hepatol 2003 Mar;1(2):89-95

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/cgh.2003.50014DOI Listing
March 2003